
Craig D. Ricci
Examiner (ID: 18610, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1614, 1628 |
| Total Applications | 1562 |
| Issued Applications | 763 |
| Pending Applications | 148 |
| Abandoned Applications | 689 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 20114995
[patent_doc_number] => 12364679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Esters for treatment of ocular inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 17/445520
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445520 | Esters for treatment of ocular inflammatory conditions | Aug 19, 2021 | Issued |
Array
(
[id] => 17426871
[patent_doc_number] => 20220054579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/404680
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404680 | Methods and compositions for treatment of lysosomal storage disorders | Aug 16, 2021 | Issued |
Array
(
[id] => 17412056
[patent_doc_number] => 20220046960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => BEVERAGE COMPOSITION AND PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/398827
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398827 | BEVERAGE COMPOSITION AND PROCESS | Aug 9, 2021 | Pending |
Array
(
[id] => 17368208
[patent_doc_number] => 20220023260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Ready to Use Ketorolac Formulations
[patent_app_type] => utility
[patent_app_number] => 17/396890
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396890 | Ready to Use Ketorolac Formulations | Aug 8, 2021 | Pending |
Array
(
[id] => 18597131
[patent_doc_number] => 20230271923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/040858
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040858 | IMAGING AND TARGETING PROGRAMMED DEATH LIGAND-1 (PD-LI) EXPRESSION | Aug 5, 2021 | Pending |
Array
(
[id] => 18075892
[patent_doc_number] => 20220401504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => USE OF MAGNOLIA FIGO EXTRACT IN THE MANUFACTURE OF COMPOUND FOR INHIBITING GROWTH OF LUNG CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/394047
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394047 | Use of Magnolia figo extract in the manufacture of compound for inhibiting growth of lung cancer cells | Aug 3, 2021 | Issued |
Array
(
[id] => 18674972
[patent_doc_number] => 20230312495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/041742
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041742
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041742 | NEW ISOBUTYRAMIDE DERIVATIVES, COSMETIC AND/OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID COMPOUNDS, AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF SENSITIVE, IN PARTICULAR INFLAMED SKIN OR INFLAMMATORY SKIN CONDITIONS | Aug 1, 2021 | Pending |
Array
(
[id] => 18581522
[patent_doc_number] => 20230263774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => OPTIMIZED SURGERY PROTOCOL AND KITS
[patent_app_type] => utility
[patent_app_number] => 18/040959
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040959 | OPTIMIZED SURGERY PROTOCOL AND KITS | Jul 29, 2021 | Pending |
Array
(
[id] => 18657619
[patent_doc_number] => 20230303543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => NOVEL STIRIPENTOL DERIVATIVE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018792
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018792
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018792 | Stiripentol derivative and use thereof | Jul 29, 2021 | Issued |
Array
(
[id] => 18656032
[patent_doc_number] => 20230301898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/018663
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018663 | EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION | Jul 29, 2021 | Pending |
Array
(
[id] => 18902638
[patent_doc_number] => 20240018123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/017997
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017997 | COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF | Jul 27, 2021 | Pending |
Array
(
[id] => 17383029
[patent_doc_number] => 20220030881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Broad-Spectrum Organic Fungicide & Bactericide
[patent_app_type] => utility
[patent_app_number] => 17/385515
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/385515 | Broad-Spectrum Organic Fungicide & Bactericide | Jul 25, 2021 | Pending |
Array
(
[id] => 17686168
[patent_doc_number] => 20220193460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => SURFACTANT-FREE FOAM FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/384996
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384996 | SURFACTANT-FREE FOAM FORMULATIONS | Jul 25, 2021 | Abandoned |
Array
(
[id] => 18784705
[patent_doc_number] => 20230372311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => COMPOSITIONS AND METHODS OF TREATING AGE-RELATED RETINAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/006176
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006176 | COMPOSITIONS AND METHODS OF TREATING AGE-RELATED RETINAL DYSFUNCTION | Jul 20, 2021 | Pending |
Array
(
[id] => 17198620
[patent_doc_number] => 20210338714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/376757
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376757 | Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity | Jul 14, 2021 | Issued |
Array
(
[id] => 19233699
[patent_doc_number] => 20240190891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/014770
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014770 | PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS | Jul 13, 2021 | Abandoned |
Array
(
[id] => 17341372
[patent_doc_number] => 20220007703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR THE TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/373840
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373840
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373840 | Method for the treatment of depression | Jul 12, 2021 | Issued |
Array
(
[id] => 18567067
[patent_doc_number] => 20230257396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => MACROCYCLES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/004829
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004829 | MACROCYCLES AND THEIR USE | Jul 7, 2021 | Pending |